BOSTON ­– Digital health platforms and advanced computational techniques are finding increasing use in big pharma, both improving and, at times, complicating the enterprise. Though varied efforts are taking shape across the world, Rachel Sha, vice president of digital business development at Sanofi SA shed light on her company's approach at BIO International Convention.